SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 21.27+0.9%Nov 18 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DeadHead who wrote (959)7/16/1997 8:10:00 PM
From: Ambrym Man   of 1693
 
I think you are right. It had crossed my mind. Maybe that is
why DeBruin has a part time job with them for $75,000 a year.
The other thing I wonder about is the fact that some of the products
were bought with Pacific Whatchamacallit from Lilly. Don't know how
that all fits in. Did Quidel pay too much and was there an indemnification clause in the sale ?. Also, in the agreement, there was the statement that as the various patents expired in different countries the payments would cease.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News